Teva Pharmaceuticals Competitors and Similar CompaniesClear all
WuXi AppTec's competitors and similar companies include Novartis, AstraZeneca, Roche and Allergan.
 WuXi AppTec WuXi AppTec (无锡药明康德新药开发股份有限公司, formerly known as WuXi PharmaTech) is a company that provides integrated research, development, and manufacturing solutions for drug discovery and production. |  Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. |  AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. |  Allergan Allergan is a healthcare company focused on developing, manufacturing, and commercializing branded pharmaceutical, device, biologic, surgical, and regenerative medicine products. | ||
Founding Date | Founding Date 2000 | Founding Date 1996 | Founding Date 1999 | Founding Date 1896 | Founding Date 1948 |
Type | Type Public | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Shanghai, CN HQ Beijing, CN Changzhou, CN Chengdu, CN Nanjing, CN Nantong, CN Shanghai, CN see more | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more | Locations Dublin, IE HQ Buenos Aires, AR Roseville, AU Machelen, BE Guarulhos, BR Las Condes, CL Bogotá, CO see more | |
Employees | Employees 39,414 | Employees 75,883 | Employees 94,300 | Employees 103,249 | Employees 10,5471% decrease |
Valuation ($) | Valuation ($) 20.7 b | Valuation ($) N/A | Valuation ($) 2.7 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) ¥43.1b (FY, 2025) | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) $58.7b (FY, 2025) | Revenue (est.) CHF61.5b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods ¥23.8b (FY, 2025) | Cost of goods $8.4b (FY, 2025) | Cost of goods $4.9b (FY, 2025) | Cost of goods CHF13.1b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit ¥21.3b (FY, 2025) | Gross profit $49.8b (FY, 2025) | Gross profit $54.2b (FY, 2025) | Gross profit CHF50.5b (FY, 2025) | Gross profit N/A |
Net income | Net income ¥19.3b (FY, 2025) | Net income $14b (FY, 2025) | Net income $10.2b (FY, 2025) | Net income CHF13.8b (FY, 2025) | Net income N/A |
Operating ⚠ | |||||
Countries | Countries N/A | Countries N/A | Countries 130 (FY, 2021) | Countries N/A | Countries 100 (Q1, 2020) |
Patients | Patients N/A | Patients 10 m (FY, 2022) | Patients N/A | Patients 22.8 m (FY, 2023) | Patients N/A |
Funding | |||||
Total funding raised | Total funding raised $ 902.6m | Total funding raised $ 6.5m | Total funding raised $ 1b | Total funding raised $ 7.8b | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Novartis
HQ
Basel, CH
Employees
75,883
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View companyAstraZeneca
HQ
Cambridge, GB
Employees
94,300
AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
View company
Roche
HQ
Basel, CH
Employees
103,249
Roche Holding is a biotech company that provides in vitro diagnostics and supplies services.
View companyAllergan
HQ
Dublin, IE
Allergan is a healthcare company focused on developing, manufacturing, and commercializing branded pharmaceutical, device, biologic, surgical, and regenerative medicine products.
View company